The endocannabinoid system: a new molecular target for the treatment of tobacco addiction
- PMID: 19128204
- PMCID: PMC3821699
- DOI: 10.2174/187152708786927859
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction
Abstract
Tobacco addiction is one of the leading preventable causes of mortality in the world and nicotine appears to be the main critical psychoactive component in establishing and maintaining tobacco dependence. Several lines of evidence suggest that the rewarding effects of nicotine, which underlie its abuse potential, can be modulated by manipulating the endocannabinoid system. For example, pharmacological blockade or genetic deletion of cannabinoid CB(1) receptors reduces or eliminates many behavioral and neurochemical effects of nicotine that are related to its addictive potential. This review will focus on the recently published literature about the role of the endocannabinoid system in nicotine addiction and on the endocannabinoid system as a novel molecular target for the discovery of medications for tobacco dependence.
Similar articles
-
The endogenous cannabinoid system modulates nicotine reward and dependence.J Pharmacol Exp Ther. 2008 Aug;326(2):483-92. doi: 10.1124/jpet.108.138321. Epub 2008 May 1. J Pharmacol Exp Ther. 2008. PMID: 18451315 Free PMC article.
-
Neuronal nicotinic receptors as brain targets for pharmacotherapy of drug addiction.CNS Neurol Disord Drug Targets. 2008 Nov;7(5):422-41. doi: 10.2174/187152708786927831. CNS Neurol Disord Drug Targets. 2008. PMID: 19128201 Review.
-
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives.Psychopharmacology (Berl). 2016 May;233(10):1765-77. doi: 10.1007/s00213-015-4196-3. Epub 2016 Jan 4. Psychopharmacology (Berl). 2016. PMID: 26728894 Review.
-
CB1 receptor antagonists for the treatment of nicotine addiction.Pharmacol Biochem Behav. 2005 Jun;81(2):387-95. doi: 10.1016/j.pbb.2005.01.024. Pharmacol Biochem Behav. 2005. PMID: 15935455 Review.
-
Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies.Addict Biol. 2008 Jun;13(2):239-52. doi: 10.1111/j.1369-1600.2008.00113.x. Addict Biol. 2008. PMID: 18482433 Free PMC article. Review.
Cited by
-
The relationship between nicotine and psychosis.Ther Adv Psychopharmacol. 2019 Jul 1;9:2045125319859969. doi: 10.1177/2045125319859969. eCollection 2019. Ther Adv Psychopharmacol. 2019. PMID: 31308936 Free PMC article. Review.
-
The future of endocannabinoid-oriented clinical research after CB1 antagonists.Psychopharmacology (Berl). 2009 Jul;205(1):171-4. doi: 10.1007/s00213-009-1506-7. Epub 2009 Mar 20. Psychopharmacology (Berl). 2009. PMID: 19300982 Free PMC article.
-
Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg.Psychopharmacology (Berl). 2016 May;233(10):1845-66. doi: 10.1007/s00213-016-4244-7. Epub 2016 Mar 30. Psychopharmacology (Berl). 2016. PMID: 27026633 Free PMC article. Review.
-
Enhancing effect of nicotine on electrical field stimulation elicited contractile responses in isolated rabbit bladder straight muscle; the role of cannabinoid and vanilloid receptors.Turk J Med Sci. 2022 Dec;52(6):1814-1820. doi: 10.55730/1300-0144.5527. Epub 2022 Dec 21. Turk J Med Sci. 2022. PMID: 36945969 Free PMC article.
-
Comorbid Cannabis and Tobacco Use in Adolescents and Adults.Curr Addict Rep. 2016 Jun 1;3(2):182-188. doi: 10.1007/s40429-016-0101-3. Curr Addict Rep. 2016. PMID: 27175326 Free PMC article.
References
-
- US Department of Health and Human Services. The health consequences of smoking: a report of the surgeon general. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; Atlanta: 2004.
-
- US Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the surgeon general. US Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; Atlanta: 2006.
-
- World Heath Organization. Updated projections of global mortality and burden of disease, 2002–2030: data sources methods and results. 2006.
-
- Department of Health and Human Services. The health benefits of smoking cessation: a report of the Surgeon General. Washington (DC): US Public Health Service, Office on Smoking and Health; 1990. - PubMed
-
- Henningfield JE, Burns DM, Dybing E. Nicotine Tob Res. 2005;7:821. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources